Hui Quan

Sanofi

Disclosure information not submitted.

Presentation(s):

• Borrowing Information of a Biomarker Endpoint for Planning a Phase III Study

  Monday, August 8, 2022

• A Case Study of 2-Stage Seamless Adaptive Sample Size Re-Estimation Design with Efficacy Interim Analysis When Slope Is the Primary Endpoint

  Wednesday, September 21, 2022

• Generalizing Treatment Effect to a Target Population with a Data-Matching Approach, However Without Individual Patient Data

  Wednesday, September 21, 2022